NEW YORK (GenomeWeb News) – Martinsried, Germany-based Kinaxo Biotechnologies today said that it has inked sales and marketing pacts in the US and Japan for its Cellular Target Profiling service.
 
In the US, New York-based BioCatalyst International will support the introduction of the service, while UK-based BioFocus DPI will provide similar support in Japan.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.